Impurities related to Argatroban

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it.

To support your analysis and help ensure the accuracy of quality processes, SZEB supply a range of Argatroban -related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.

The following are some of the impurities of Argatroban :